Subscribe To
MSSTF / Mindset Pharma granted allowance for patent covering its short-duration novel psychedelic medications
Content Topics
Mindset
Pharma
Granted
Allowance
Patent
Covering
Short duration
Psychedelic
Medications
Stock
MSSTF
MSSTF News
By Proactive Investors
August 31, 2023
Mindset Pharma to be acquired by Otsuka Pharmaceutical in all-cash deal
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has agreed to be acquired by Otsuka Pharmaceutical Co, Ltd, through its wholly-owned Ots more_horizontal
By Proactive Investors
June 22, 2023
Mindset Pharma's Phase 2 psilocin prodrug study gets green light from UK regulators
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) has received approval from the UK Medicines and Healthcare products Regulatory Authority and the Research E more_horizontal
By Proactive Investors
April 26, 2023
Mindset Pharma files two international patent applications under the Patent Cooperation Treaty
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) said it has filed two international patent applications under the Patent Cooperation Treaty (PCT) to prote more_horizontal
By Proactive Investors
March 28, 2023
Mindset Pharma CEO discusses expansion of drug discovery efforts into novel non-hallucinogenic therapeutics
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF). is expanding its drug discovery efforts into novel non-hallucinogenic therapeutics in light of the success more_horizontal
By Proactive Investors
March 6, 2023
Mindset Pharma and PharmAla complete first sale of pharmaceutical-grade psilocybin into growing Australian market via sales partnership
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) said PharmAla Biotech (CSE:MDMA) Holdings Inc has completed the first sale of a quantity of Mindset's pharm more_horizontal
By Proactive Investors
February 2, 2023
Mindset Pharma receives another allowance for US patent application expanding composition of matter for Family 1 psilocybin analogs
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) told investors that the US Patent and Trademark Office has granted allowance for another of its Family 1 p more_horizontal
By Proactive Investors
January 20, 2023
Mindset Pharma receives allowance for US patent application covering lead psychedelic therapeutic candidate
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) told investors that the US Patent and Trademark Office (USPTO) has granted allowance for its patent applica more_horizontal
By GlobeNewsWire
December 6, 2022
Mindset Pharma to Participate in Upcoming Conferences in December 2022
TORONTO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug more_horizontal